Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer

Clinical trial NCT03810807 · COMPLETED

Trial details

NCT number: NCT03810807
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Non-small Cell Lung Cancer

Start date: 2019-01-17
Primary completion: 2025-12-15
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.